| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | BKUH | Common Stock | 24,160,007 | 31 Jul 2023 | Direct | ||||||
| holding | BKUH | Common Stock | 6,000,000 | 31 Jul 2023 | Mentone Ltd. | F1 | |||||
| holding | BKUH | Series A Preferred | 4 | 31 Jul 2023 | Cell Science Holdings Ltd. | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | BKUH | Stock Option | 100,000 | 31 Jul 2023 | Common Stock | 100,000 | $5.10 | Direct |
| Id | Content |
|---|---|
| F1 | 6,000,000 Shares of Common Stock of are owned by Mentone Ltd., of which Mr. Whitton is a 34% owner. |
| F2 | Cell Sience owns 4 Shares of Series A Preferred Stock. Menton Ltd is the owner of 30% of Cell Science, and Mr. Whitton is a 34% owner of Mentone Ltd. |